Vagus nerve & neuromodulation wearables (Apollo Neuro, Sensate, Pulsetto, Truvaga, Nurosym, Flow Neuroscience, Muse S, Hapbee)

What it claims

• Stimulates the vagus nerve and shifts you into parasympathetic 'rest-and-digest'
• Improves HRV, sleep quality, recovery, focus, anxiety, mood
• Non-invasive, drug-free, side-effect free
• Replaces meditation / therapy / medication for stress and burnout

What the label is not telling you

• Apollo Neuro (€349) — A haptic wristband/ankle band that delivers low-frequency vibration patterns. It is NOT vagus nerve stimulation. Apollo's own published research is a small 2020 University of Pittsburgh study (n=82, healthy adults) showing modest HRV improvement during wear. Independent replications are thin. Mechanism is interoceptive entrainment — your brain pattern-matches the vibration as a safety cue — not bioelectronic neuromodulation. Honest verdict: a well-designed haptic cue that some people genuinely co-regulate with, marketed with neuroscience language it does not earn.
• Sensate (€249) — A pebble that sits on your sternum and delivers infrasonic vibration to the chest wall, paired with an audio track. Claims to tone the vagus nerve via sternal resonance. Published evidence: one 2022 pilot study (BetterUp / Sensate, n=84) showing reduced self-reported stress. No independent HRV trial of meaningful size. The mechanism is plausible (sternal vagal afferents exist) but unproven at this dose. Many users report it works — likely a real combination of slow breathing entrained by the audio + thoracic interoception + ten quiet minutes lying down. The device is doing some of the work; the protocol is doing more.
• Pulsetto (€269) — Transcutaneous auricular vagus nerve stimulation (taVNS) via a neck-worn electrode. This IS direct electrical stimulation of the cervical vagus branch. The category (taVNS) has growing peer-reviewed evidence for HRV, inflammation markers and depression. Pulsetto's specific device has limited independent validation versus the medical-grade predicates it borrows from. Side-effect profile is mild (skin tingling, occasional hoarseness). Not FDA-cleared as a medical device — sold as a wellness consumer product, which is regulatorily convenient and clinically ambiguous.
• Truvaga 350 (€399, electroCore) — Handheld cervical vagus nerve stimulator. Sister product to gammaCore, which IS FDA-cleared for migraine and cluster headache. Truvaga itself is sold as a wellness device (same hardware, different regulatory pathway). The strongest peer-reviewed VNS device data in the consumer space sits with this hardware family. Real mechanism, real effect on HRV in published trials. Expensive, requires daily use, and the wellness positioning obscures that this is essentially a medical device with the indication stripped off the box.
• Nurosym (€699, Parasym) — taVNS via an ear-clip electrode. CE-marked as a medical device in Europe. Strongest published evidence base of the consumer taVNS category — multiple peer-reviewed trials on HRV, long-COVID autonomic dysfunction, and post-operative inflammation. Most expensive of the group, and the only one we would describe as a medical device that is honestly marketed.
• Flow Neuroscience (€459 + €19/mo) — At-home tDCS (transcranial direct-current stimulation) headset for depression, CE-marked Class IIa in Europe. Real bioelectronics, real published evidence (the 2023 Lancet Digital Health trial showed efficacy vs sham for major depressive disorder). This is a medical device. Sold direct-to-consumer in Europe (US is investigational). Not a wellness toy; should be used with clinical oversight even though the brand markets it as accessible.
• Muse S (€399) — EEG + PPG headband for meditation and sleep tracking. Does not stimulate anything — it measures. The EEG is consumer-grade (4 electrodes), the biofeedback is reasonable, the sleep staging is moderately accurate vs polysomnography (good for trends, not diagnostic). Useful as a meditation feedback tool if you already meditate. Useless as a 'fix-your-brain' device, which is not really how Muse markets it but is how it gets sold by influencers.
• Hapbee (€419) — Wearable that claims to deliver 'ultra-low-frequency electromagnetic signals' that mimic the effects of caffeine, melatonin, nicotine, etc. The published evidence is essentially absent at the consumer device level. The underlying ulRFE patent claims are not supported by independent replication in any reputable neuroscience journal. Of the eight devices reviewed, this is the one we have the lowest confidence in mechanistically. Treat as experimental.

Effect on the nervous system

Genuine, but stratified — and rarely as large as the marketing suggests. The medical-grade taVNS and VNS devices (Nurosym, Truvaga, Pulsetto in that order of evidence) do measurably modulate vagal tone in published trials, typically on the order of 5–15% HRV change during stimulation, with effects partially carrying over for 30–90 minutes after. tDCS (Flow) modulates cortical excitability and has a real antidepressant effect for a subset of users. Haptic devices (Apollo, Sensate) work primarily by giving the nervous system a predictable interoceptive cue to entrain to — closer in mechanism to weighted-blanket-plus-breathwork than to vagus nerve stimulation. EEG headbands (Muse) do not stimulate; they create a feedback loop, which is genuinely useful if you have an existing practice and inert if you don't. Hapbee sits outside the evidence base. Critical caveat across all of them: no device replaces sleep, daylight, food timing, social connection, or movement. Stacking a €700 device on a dysregulated baseline is asking the device to do work that belongs upstream.

Who it might suit

Adults with a working nervous-system baseline who want to add a targeted bioelectronic tool: Nurosym or Truvaga for evidence-backed vagal stimulation, Flow Neuroscience for clinically supervised at-home tDCS for depression, Muse S as a feedback layer for an existing meditation practice. Apollo and Sensate suit people who genuinely co-regulate with haptic / interoceptive cues and value a 10-minute daily ritual more than the underlying mechanism. Pulsetto is a reasonable lower-cost entry into taVNS for people who understand the device is not medical-grade.

Who should skip it

Anyone with an implanted pacemaker, cochlear implant, or other active implant (all VNS/taVNS/tDCS devices). Active or unstable cardiac arrhythmia, history of seizure (tDCS particularly), pregnancy, and active psychiatric crisis without clinician oversight (Flow specifically). Anyone hoping a €400 device will substitute for sleep, sunlight, food, movement, and human connection — the device cannot out-stimulate a dysregulated foundation. Anyone who has not yet built the 30-day baseline practice in the Burnout & wired-tired anchor — buy the practice first, then layer the device.

Bottom line

Of the eight devices reviewed, the published-evidence ranking is roughly: Nurosym ≈ Flow Neuroscience (medical-grade, real data) > Truvaga > Pulsetto (real taVNS, lighter device-specific evidence) > Sensate > Apollo Neuro (interoceptive cueing, modest data, real subjective benefit for some) > Muse S (measurement only, useful with a practice) > Hapbee (evidence absent). None of them replaces nervous-system regulation work; the best of them amplifies it. If you are spending €400+ on a device before you have a daily breath practice, consistent sleep window, morning daylight, and basic interoceptive literacy, you are buying a Ferrari for a road you have not yet paved. Start with the Wired & tired anchor, build the baseline for 30 days, then — if you still want a device — Nurosym or Truvaga are the two we would actually spend our own money on. Verified neuro-tool picks live at thecodex.world.